News

But its success requires a long-term vision.

Data Book explores consent through the story of Henrietta Lacks and talks germline editing with Marcy Darnovsky, Ph.D.

The AI sector is growing at breakneck speed.

It’s difficult to make long-term predictions about which patients will die, but some worry that more accurate tools might affect healthcare spending.

Algorithms and AI are only part of the equation.

What the UnityPoint Health attack means.

23andMe, Ancestry and others agreed to detailed transparency, separate consent for third-party sharing and limits on police disclosure.

How analytics can help healthcare organizations and professionals.

Invaluable insights await those who do.

The direct-to-consumer genetic testing market goes further in the green.

Sangamo, Verily and IBM all made headlines.

Technology to revolutionize insurance ID cards exists. But few insurers have embraced it.

It’s time to invest in the push toward interoperability.

Why EHRs improve outcomes, however, is unclear.

Health systems must improve their financial performance and patient care.

But data become more important as time goes on.

Healthcare can leverage the EHR to fight addiction.

Data and AI are at the heart of the latest partnership for a very busy IBM.

New research suggests digital strategies work without breaking the bank.

Credentialing and identity verification are critical but troubled processes.

Kevin Campbell, M.D., will lead a webinar on data, value and precision cardiovascular medicine.

The pharma giant hopes to use the data for drug discovery.

Can business process outsourcing help healthcare emulate Amazon?

What does the Center for Biomedical Blockchain Research aim to accomplish?

But the industry can adopt strategies to protect patient data.

The gene-editing company paid $84.2 million for the French business.

The contested civil complaint might shed light on his departure from the genomics heavyweight.

Its cloud-based solutions connect payers and providers.